Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)

NCT03002376

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Radboud University Medical Center Nijmegen, Netherlands

Military Medical Academy Belgrade, Serbia

Seoul National University Hospital Seoul, South Korea

Asan Medical Center Seoul, South Korea

View Trial Details

Completed

Health Communication in Families

NCT00597961

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

The Incidence of Breast and Other Cancers Among Female Flight Attendants

NCT00342407

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations: National Institute for Occupational Safety and Health (NIOSH) Cincinnati, Ohio, United States

View Trial Details

Completed

Study of Pembrolizumab (MK-3475) in Participants With Advanced Melanoma (MK-3475-041/KEYNOTE-041)

NCT02180061

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

Study of Karenitecin (BNP1350) to Treat Malignant Melanoma

NCT00062491

Conditions: Melanoma, Neoplasm, Neoplasms, +10 more
Locations: For Information call 210-614-1701 for a site near you Tampa, Florida, United States

View Trial Details

Completed

Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy

NCT01449279

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma

NCT00912418

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Virginia Charlottesville, Virginia, United States

View Trial Details

Completed

High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI

NCT01266603

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

NCT02583516

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Hospital Universitario Donostia Donostia / San Sebastian, Guipuzcoa, Spain

Hospital General Universitario Santa Lucía Cartagena, Murcia, Spain

Hospital Clínic de Barcelona Barcelona, Spain

Hospital del Mar Barcelona, Spain

View all 18 locations

View Trial Details

Completed

Trametinib With GSK2141795 in BRAF Wild-type Melanoma

NCT01941927

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: University of California, San Francisco San Francisco, California, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Melanoma

Melanoma trial results

Related conditions